These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 19106392

  • 1. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study.
    Ninomiya T, Kiyohara Y, Tokuda Y, Doi Y, Arima H, Harada A, Ohashi Y, Ueshima H, Japan Arteriosclerosis Longitudinal Study Group.
    Circulation; 2008 Dec 16; 118(25):2694-701. PubMed ID: 19106392
    [Abstract] [Full Text] [Related]

  • 2. Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.
    Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S.
    Hypertens Res; 2008 Mar 16; 31(3):433-41. PubMed ID: 18497462
    [Abstract] [Full Text] [Related]

  • 3. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG.
    Circulation; 2006 Jun 13; 113(23):2713-23. PubMed ID: 16754803
    [Abstract] [Full Text] [Related]

  • 4. The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study.
    Kokubo Y, Okamura T, Watanabe M, Higashiyama A, Ono Y, Miyamoto Y, Furukawa Y, Kamide K, Kawanishi K, Okayama A, Yoshimasa Y.
    Hypertens Res; 2010 Dec 13; 33(12):1238-43. PubMed ID: 20927111
    [Abstract] [Full Text] [Related]

  • 5. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.
    Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB, Gaziano JM, Vasan RS.
    Arch Intern Med; 2007 May 14; 167(9):879-85. PubMed ID: 17502528
    [Abstract] [Full Text] [Related]

  • 6. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M, Kawar B, El Nahas AM.
    Nephron Clin Pract; 2009 May 14; 113(1):c16-23. PubMed ID: 19590231
    [Abstract] [Full Text] [Related]

  • 7. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Rahman M, Brown CD, Coresh J, Davis BR, Eckfeldt JH, Kopyt N, Levey AS, Nwachuku C, Pressel S, Reisin E, Walworth C, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.
    Arch Intern Med; 2004 May 10; 164(9):969-76. PubMed ID: 15136305
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT, PREVEND Study Group.
    Nephrol Dial Transplant; 2008 Dec 10; 23(12):3851-8. PubMed ID: 18641082
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease.
    Sengstock D, Sands RL, Gillespie BW, Zhang X, Kiser M, Eisele G, Vaitkevicius P, Kuhlmann M, Levin NW, Hinderliter A, Rajagopalan S, Saran R.
    Nephrol Dial Transplant; 2010 Mar 10; 25(3):853-61. PubMed ID: 19854848
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL.
    Am J Kidney Dis; 2009 Apr 10; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan.
    Cheng TY, Wen SF, Astor BC, Tao XG, Samet JM, Wen CP.
    Am J Kidney Dis; 2008 Dec 10; 52(6):1051-60. PubMed ID: 18706747
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
    Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, Kim WS, Suh BS, Jeong C, Yoon K.
    Am J Kidney Dis; 2009 Jan 10; 53(1):59-69. PubMed ID: 18838200
    [Abstract] [Full Text] [Related]

  • 18. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
    Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ.
    Am J Kidney Dis; 2005 Sep 10; 46(3):455-63. PubMed ID: 16129207
    [Abstract] [Full Text] [Related]

  • 19. Chronic kidney disease increases cardiovascular mortality in 80-year-old subjects in Japan.
    Kagiyama S, Matsumura K, Ansai T, Soh I, Takata Y, Awano S, Sonoki K, Yoshida A, Takehara T, Iida M.
    Hypertens Res; 2008 Nov 10; 31(11):2053-8. PubMed ID: 19098377
    [Abstract] [Full Text] [Related]

  • 20. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study.
    Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y.
    Am Heart J; 2009 Oct 10; 158(4):629-36. PubMed ID: 19781424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.